Prostaglandins and interleukin-1β in the hypothalamic-pituitary- adrenal response to systemic phenylephrine under basal and stress conditions

Journal of Physiology and Pharmacology

Volumn 59, Issue 3, 2008, Pages 563-575

  Gadek Michalska A ^a   Bugajski, A J ^b   Bugajski, J ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

1 adrenergic agonist; COX 1; COX 2 inhibitors; IL 1 and PG in HPA stimulation; Interleukin 1 receptor antagonist

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PHENYLEPHRINE; PIROXICAM; PROSTAGLANDIN; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; CROWDING; DRUG EFFICACY; DRUG MECHANISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; RAT; STRESS; ANIMAL; DRUG EFFECT; DRUG POTENTIATION; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MENTAL STRESS; METABOLISM; SOCIAL ENVIRONMENT; WISTAR RAT;

ADRENERGIC ALPHA-AGONISTS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; CORTICOSTERONE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-1BETA; MALE; PHENYLEPHRINE; PITUITARY-ADRENAL SYSTEM; PROSTAGLANDINS; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; SOCIAL ENVIRONMENT; STRESS, PSYCHOLOGICAL;

EID: 53649095777     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Turnbull AV, Rivier CL. Regulation of the hypothalamic-pituitary adrenal axis by cytokines: actions and mechanisms of action. Physiol Revs 1999; 79: 1-44.
2. Sang N, Chen C. Lipid signaling and synaptic plasticity. Neuroscientist 2006; 12: 425-434.
3. Bugajski J, Głód R, Ga̧dek-Michalska A, Bugajski AJ. Involvement of constitutive (COX-1) and inducible cyclooxygenase (COX-2) in the adrenergic-induced ACTH and corticosterone secretion. J Physiol Pharmacol 2001; 52: 795-809.
4. Bugajski J, Ga̧dek-Michalska A, Głód R, Bugajski AJ. Effect of social stress on COX-1 and COX-2-induced alterations in the adrenergic agonists-evoked hypothalamic-pituitary-adrenal responses. J Physiol Pharmacol 2001; 52: 811-822.
5. Ferri CC, Ferguson AV. Interleukin-1β depolarizes paraventricular nucleus parvocellular neurons. J Neuroendocrinol 2003; 15: 126-133.
6. Rivest S. How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 2001; 26: 761-788.
7. Dunn AJ. Effects of the IL-1 receptor antagonist on the IL-1- and endotoxin-induced activation of the HPA axis and cerebral biogenic amines in mice. Neuroimmunomodulation 2000; 7: 36-45.
8. Quan N, Herkenham M. Connecting cytokines and brain: a review of current issues. Histol Histopathol 2002; 17: 273-288.
9. John CD. Buckingham JC. Cytokines: regulation of the hypothalamo- pituitary-adrenal response during crowding stress. J Physiol Pharmacol 2006; 57: 463-477.
10. Cunha JM, Cunha FQ, Poole S, Ferreira SH. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist. Brit J Pharmacol 2000; 130: 1418-1424.
11. Kapcala LP, He JR, Gao Y, Pieper JO, DeTolla LJ. Subdiaphragmatic vagotomy inhibitors intraabdominal interleukin-1β stimulation of adrenocorticotropin secretion. Brain Research 1996; 728: 247-254.
12. Fleshner M, Goehler LE, Hermann J, Relton JK, Maier SF, Watkins LR. Interleukin-1β induced corticosterone elevation and hypothalamic NE depletion is vagally mediated. Brain Res Bull 1995; 37: 605-610.
13. Bugajski AJ, Żurowski D, Thor P, Ga̧dek-Michalska A. Effect of subdiaphragmatic vagotomy and cholinergic agents in the hypothalamic-pituitary- adrenal axis activity. J Physiol Pharmacol 2007; 58: 335-347.
14. Konsman JP, Tridon V, Dantzer R. Diffusion and action of intracerebroventricularly injected interleukin-1 in the CNS. Neuroscience 2000; 101: 957-967.
15. Grinevich V, Ma XM, Herman JP, Jezova D, Akmayev I, Aguilera G. Effect of repeated lipopolysaccharide administration on tissue cytokine expression and hypothalamic-pituitary-adrenal axis activity in rats. J Neuroendocrinol 2001; 13: 711-723.
16. Schmidt ED, Aguilera G, Binnekade R, Tilders FJ. Single administration of interleukin-1 increased corticotropin releasing hormone and corticotropin releasing hormone receptor mRNA in the hypothalamic paraventricular nucleus which paralleled long-lasting (weeks) sensitization to emotional stressors. Neuroscience 2003; 116: 275-283.
17. Ferri CC, Ferguson AV. Prostaglandin E2 mediates cellular effects of interleukin-1β on parvocellular neurons in the paraventricular nucleus of the hypothalamus. J Neuroendocrinol 2005; 17: 498-508.
18. Buller KM, Xu Y, Day TA. Indomethacin attenuates oxytocin and hypothalamic-pituitary-adrenal axis responses to systemic interleukin-1β. J Neuroendocrinol 1998; 10: 519-528.
19. Parsadaniantz SM, Lebeau A, Duval P, Grimaldi B, Terlain B, Kerdelhue B. Effects of the inhibition of cyclo-oxygenase 1 or 2 or 5-lipoxygenase on the activation of the hypothalamic-pituitary-adrenal axis induced by interleukin-1β in the male rat. J Neuroendocrinology 2000; 12: 766-773.
20. Cragnolini AB, Caruso C, Lasaga M, Scimonelli TN. A-MSH and γ-MSH modulate early release of hypothalamic PGE2 and NO induced by IL-1β differently. Neurosci Lett 2006; 409: 168-172.
21. 1D-adrenergic receptor mRNA in the rat brain and spinal cord. J Chem Neuroanatomy 1997; 13: 115-139.
22. 1A-adrenergic receptor in female rat brain regions involved in stress and neuroendocrine function. Neurochem International 1999; 35: 383-391.
23. Carrasco GA, Van de Kar LD. Neuroendocrine pharmacology of stress. Eur J Pharmacol 2003; 463: 235-272.
24. Ericsson A, Arias C, Sawchenko PE. Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1. J Neurosci, 1997: 15: 7166-7179.
25. Tilbrook AJ, Clarke LJ. Neuroendocrine mechanisms of innate states of attenuated responsiveness of the hypothalamo-pituitary-adrenal axis to stress. Frontiers in Neuroendocrinology 2006; 27: 285-307.
26. Bugajski AJ, Ga̧dek-Michalska A, Bugajski J. The involvement of nitric oxide and prostaglandins in the cholinergic stimulation of hypothalamic-pituitary-adrenal response during crowding stress. J Physiol Pharmacol 2006; 57: 463-477.
27. Johnson JD, O'Connor KA, Watkins LR, Maier SF. The role of IL-1β in stress-induced sensitization of proinflammatory cytokine and corticosterone responses. Neuroscience 2004; 127: 569-577.
28. Bornstein SR, Chrousos GP. Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. Clinical Review 104. J Clin Endocrinol Metab 1999; 84: 1729-1736.
29. Delarue C, Contesse V, Lenglet S, Perraudin V, Lefebvre H, Kodjo M, Leboulenger F, Yon L, Gallo-Payet N, Vaudry H. Role of neurotransmitters and neuropeptides in the regulation of the adrenal cortex. Rev Endocrin Metab Disorders 2001; 2: 253-267.
30. Andreis PG, Neri G, Belloni AS, Mazzocchi G, Kasprzak A, Nussdorfer GG. Interleukin-1β enhances corticosterone secretion by acting directly on the rat adrenal gland. Endocrinology 1991; 129; 53-57.
31. Ga̧dek-Michalska A, Bugajski J. Nitric oxide mediates the interleukin-1β- and nicotine induced hypothalamic-pituitary-adrenocortical response during social stress. J Physiol Pharmacol 2005; 56: 491-503.
32. Rivier C. Blockade of nitric oxide formation augments adrenocorticotropin released by bloodborne interleukin-1 beta role of vasopressin, prostaglandins, and alpha 1-adrenergic receptors. Endocrinology; 1995: 136: 3597-3603.